Biopsy diagnosis of inherited liver disease

Surgical Pathology Clinics

Volumn 3, Issue 3, 2010, Pages 743-768

  Roy, Angshumoy ^a   Finegold, Milton J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cholestatic; Cirrhotic; Metabolic; Steatotic; Storage pattern

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALBUMIN; ALPHA 1 ANTITRYPSIN; ALPHA GLUCOSIDASE; AMINOTRANSFERASE; AMMONIA; BETA GALACTOSIDASE; BETA GLUCOSIDASE; BILIRUBIN; CERAMIDASE; COPPER; COPPER EXPORTING ADENOSINE TRIPHOSPHATASE; ELECTROLYTE; FIBROCYSTIN; FUMARYLACETOACETASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; GLUTARALDEHYDE; GLYCOGEN; GLYCOSAMINOGLYCAN; IRON; JAGGED1; KETONE; LACTIC ACID; PHENOBARBITAL; PYRUVIC ACID; SPHINGOMYELIN PHOSPHODIESTERASE; SUCCINYLACETONE; UNINDEXED DRUG; URIC ACID;

ALAGILLE SYNDROME; ALBUMIN BLOOD LEVEL; ALGORITHM; ALPHA 1 ANTITRYPSIN DEFICIENCY; AMINOACIDURIA; AMINOTRANSFERASE BLOOD LEVEL; AMMONIA BLOOD LEVEL; AMNION FLUID; BILE ACID SYNTHESIS; BILE DUCT; BILIRUBIN BLOOD LEVEL; BLOOD GAS; CHOLANGITIS; CHOLESTASIS; CONSANGUINITY; DIFFERENTIAL DIAGNOSIS; ELECTROLYTE BLOOD LEVEL; ENZYME ACTIVITY; ENZYME DEFICIENCY; FAMILY HISTORY; FARBER DISEASE; FIBROBLAST; FIBROSIS; FROZEN SECTION; GALACTOSEMIA; GALACTOSIALIDOSIS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GAUCHER DISEASE; GENE MUTATION; GENE SEQUENCE; GENETIC DISORDER; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; GLYCOGEN STORAGE DISEASE TYPE 2; GROWTH RETARDATION; HISTIOCYTE; HISTOPATHOLOGY; HUMAN; IMAGING; INFANTILE REFSUM DISEASE; IRON OVERLOAD; KIDNEY POLYCYSTIC DISEASE; KUPFFER CELL; LABORATORY TEST; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LEUKOCYTE; LEUKODYSTROPHY; LIVER BIOPSY; LIVER CELL; LIVER CIRRHOSIS; LIVER DISEASE; LIVER HISTOLOGY; METABOLISM; MICROSCOPY; MICROVILLUS; MITOCHONDRIAL DNA DEPLETION SYNDROME; MOLECULAR GENETICS; MUCOPOLYSACCHARIDOSIS; NEOPLASM; NIEMANN PICK DISEASE; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PATHOLOGIST; PORTAL HYPERTENSION; PORTAL VEIN; PRIORITY JOURNAL; PROTHROMBIN TIME; REVIEW; STEATOSIS; STORAGE; TISSUE; TYROSINEMIA; UREA CYCLE DISORDER; URIC ACID BLOOD LEVEL; WILSON DISEASE; ZELLWEGER SYNDROME;

EID: 77958117854     PISSN: 18759181     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.path.2010.06.006     Document Type: Review

References (75)

1. Scriver C.R. The metabolic & molecular bases of inherited disease 2001, McGraw-Hill, New York. 8th edition.
2. Suchy F.J., Sokol R.J., Balistreri W.F. Liver disease in children 2007, Cambridge University Press, Cambridge (NY). 3rd edition.
3. Jevon G., Dimmick J. Metabolic disorders in childhood. Pathology of pediatric gastrointestinal and liver disease 2004, 270-299. Springer-Verlag, Inc, New York. 1st edition. P. Russo, E.D. Ruchelli, D.A. Piccoli (Eds.).
4. Knisely A.S. Hepatocellular and familial cholestasis. Pathology of pediatric gastrointestinal and liver disease 2004, 237-250. Springer-Verlag, Inc, New York. 1st edition. P. Russo, E.D. Ruchelli, D.A. Piccoli (Eds.).
5. Ruchelli E.D., Rand E.B., Haber B.A. Hepatitis and liver failure in infancy and childhood. Pathology of pediatric gastrointestinal and liver disease 2004, 251-269. Springer-Verlag, Inc, New York. 1st edition. P. Russo, E.D. Ruchelli, D.A. Piccoli (Eds.).
6. Russo P., Loomes K.M. Diseases of the intrahepatic biliary tree-paucity of intrahepatic bile ducts. Pathology of pediatric gastrointestinal and liver disease 2004, 220-236. Springer-Verlag, Inc, New York. 1st edition. P. Russo, E.D. Ruchelli, D.A. Piccoli (Eds.).
7. Finegold M.J. Hepatic tumors in childhood. Pathology of pediatric gastrointestinal and liver disease 2004, 300-346. Springer-Verlag, Inc, New York. 1st edition. P. Russo, E.D. Ruchelli, D.A. Piccoli (Eds.).
8. Munnich A., Rotig A., Chretien D., et al. Clinical presentations and laboratory investigations in respiratory chain deficiency. Eur J Pediatr 1996, 155(4):262-274.
9. Angdisen J., Dasouki M., Ibdah J.A. Inborn errors of mitochondrial fatty acid oxidation. Liver disease in children 2007, 767-802. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
10. Ghishan F.K., Zawaideh M. Inborn errors of carbohydrate metabolism. Liver disease in children 2007, 595-625. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
11. Jacquemin E. Progressive familial intrahepatic cholestasis. Genetic basis and treatment. Clin Liver Dis 2000, 4(4):753-763.
12. Suchy F.J., Shneider B.L. Familial hepatocellular cholestasis. Liver disease in children 2007, 310-325. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
13. Suchy F.J. Approach to the infant with cholestasis. Liver disease in children 2007, 179-189. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
14. Bull L.N., van Eijk M.J., Pawlikowska L., et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998, 18(3):219-224.
15. Strautnieks S.S., Bull L.N., Knisely A.S., et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998, 20(3):233-238.
16. de Vree J.M., Jacquemin E., Sturm E., et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998, 95(1):282-287.
17. Jacquemin E. Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseases. Semin Liver Dis 2001, 21(4):551-562.
18. Schwarz M., Wright A.C., Davis D.L., et al. The bile acid synthetic gene 3beta-hydroxy-Delta(5)-C(27)-steroid oxidoreductase is mutated in progressive intrahepatic cholestasis. J Clin Invest 2000, 106(9):1175-1184.
19. Mills K.A., Mushtaq I., Johnson A.W., et al. A method for the quantitation of conjugated bile acids in dried blood spots using electrospray ionization-mass spectrometry. Pediatr Res 1998, 43(3):361-368.
20. Setchell K.D., Heubi J.E. Defects in bile acid biosynthesis-diagnosis and treatment. J Pediatr Gastroenterol Nutr 2006, 43(Suppl 1):S17-22.
21. Lemonde H.A., Custard E.J., Bouquet J., et al. Mutations in SRD5B1 (AKR1D1), the gene encoding delta(4)-3-oxosteroid 5beta-reductase, in hepatitis and liver failure in infancy. Gut 2003, 52(10):1494-1499.
22. Chagnon P., Michaud J., Mitchell G., et al. A missense mutation (R565W) in cirhin (FLJ14728) in North American Indian childhood cirrhosis. Am J Hum Genet 2002, 71(6):1443-1449.
23. McDaniell R., Warthen D.M., Sanchez-Lara P.A., et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006, 79(1):169-173.
24. Li L., Krantz I.D., Deng Y., et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997, 16(3):243-251.
25. Imrie J., Vijayaraghaven S., Whitehouse C., et al. Niemann-Pick disease type C in adults. J Inherit Metab Dis 2002, 25(6):491-500.
26. Moser H.W. Genotype-phenotype correlations in disorders of peroxisome biogenesis. Mol Genet Metab 1999, 68(2):316-327.
27. Watkins P.A., Schwarz K.B. Peroxisomal diseases. Liver disease in children 2007, 840-857. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
28. Wanders R.J., Waterham H.R. Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet 2005, 67(2):107-133.
29. Summerfield J.A., Nagafuchi Y., Sherlock S., et al. Hepatobiliary fibropolycystic diseases. A clinical and histological review of 51 patients. J Hepatol 1986, 2(2):141-156.
30. Rossetti S., Torra R., Coto E., et al. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney Int 2003, 64(2):391-403.
31. van Mil S.W., van der Woerd W.L., van der Brugge G., et al. Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11. Gastroenterology 2004, 127(2):379-384.
32. Carlton V.E., Pawlikowska L., Bull L.N. Molecular basis of intrahepatic cholestasis. Ann Med 2004, 36(8):606-617.
33. Visapaa I., Fellman V., Vesa J., et al. GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 2002, 71(4):863-876.
34. Burrow T.A., Bove K.E., Grabowski G.A. The liver in lysosomal storage diseases. Liver disease in children 2007, 714-735. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
35. Andersen D.H. Familial cirrhosis of the liver with storage of abnormal glycogen. Lab Invest 1956, 5(1):11-20.
36. Antonarakis S.E., Valle D., Moser H.W., et al. Phenotypic variability in siblings with Farber disease. J Pediatr 1984, 104(3):406-409.
37. van Lijnschoten G., Groener J.E., Maas S.M., et al. Intrauterine fetal death due to Farber disease: case report. Pediatr Dev Pathol 2000, 3(6):597-602.
38. Sogawa H., Horino K., Nakamura F., et al. Chronic Niemann-Pick disease with sphingomyelinase deficiency in two brothers with mental retardation. Eur J Pediatr 1978, 128(4):235-240.
39. Shin Y.S. Glycogen storage disease: clinical, biochemical, and molecular heterogeneity. Semin Pediatr Neurol 2006, 13(2):115-120.
40. Fromenty B., Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 1997, 26(Suppl 2):43-53.
41. Sokol R.J. Mitochondrial hepatopathies. Liver disease in children 2007, 803-829. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
42. IJlst L., Wanders R.J., Ushikubo S., et al. Molecular basis of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of the major disease-causing mutation in the alpha-subunit of the mitochondrial trifunctional protein. Biochim Biophys Acta 1994, 1215(3):347-350.
43. Yokota I., Indo Y., Coates P.M., et al. Molecular basis of medium chain acyl-coenzyme A dehydrogenase deficiency. An A to G transition at position 985 that causes a lysine-304 to glutamate substitution in the mature protein is the single prevalent mutation. J Clin Invest 1990, 86(3):1000-1003.
44. Cross N.C., de Franchis R., Sebastio G., et al. Molecular analysis of aldolase B genes in hereditary fructose intolerance. Lancet 1990, 335(8685):306-309.
45. Odievre M., Gentil C., Gautier M., et al. Hereditary fructose intolerance in childhood. Diagnosis, management, and course in 55 patients. Am J Dis Child 1978, 132(6):605-608.
46. Oglesbee D., Rinaldo P. Laboratory diagnosis of inborn errors of metabolism. Liver disease in children 2007, 531-544. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
47. Bull P.C., Thomas G.R., Rommens J.M., et al. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993, 5(4):327-337.
48. Marsden C.D. Wilson's disease. Q J Med 1987, 65(248):959-966.
49. Johnson K., Alton H.M., Chapman S. Evaluation of mebrofenin hepatoscintigraphy in neonatal-onset jaundice. Pediatr Radiol 1998, 28(12):937-941.
50. O'Connor J.A., Sokol R.J. Copper metabolism and copper storage disorders. Liver disease in children 2007, 626-660. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
51. Lindblad B., Lindstedt S., Steen G. On the enzymic defects in hereditary tyrosinemia. Proc Natl Acad Sci U S A 1977, 74(10):4641-4645.
52. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996, 13(4):399-408.
53. Jonas M.M., Perez-Atayde A.R. Fibrocystic liver disease. Liver disease in children 2007, 928-942. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
54. Jorquera R., Tanguay R.M. Fumarylacetoacetate, the metabolite accumulating in hereditary tyrosinemia, activates the ERK pathway and induces mitotic abnormalities and genomic instability. Hum Mol Genet 2001, 10(17):1741-1752.
55. Mitchell G., Russo P.A., Dubois J., et al. Tyrosinemia. Liver disease in children 2007, 694-713. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
56. Adams P.C., Deugnier Y., Moirand R., et al. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997, 25(1):162-166.
57. Ramrakhiani S., Bacon B.R. Hemochromatosis: advances in molecular genetics and clinical diagnosis. J Clin Gastroenterol 1998, 27(1):41-46.
58. Knisely A.S., Narkewicz M.R. Iron storage disorders. Liver disease in children 2007, 661-676. Cambridge University Press, Cambridge (NY). 3rd edition. F.J. Suchy, R.J. Sokol, W.F. Balistreri (Eds.).
59. Kowdley K.V. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004, 127(5 Suppl 1):S79-86.
60. Franco L.M., Krishnamurthy V., Bali D., et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 2005, 28(2):153-162.
61. Howell R.R., Stevenson R.E., Ben-Menachem Y., et al. Hepatic adenomata with type 1 glycogen storage disease. JAMA 1976, 236(13):1481-1484.
62. Nakamura T., Ozawa T., Kawasaki T., et al. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors. J Gastroenterol Hepatol 2001, 16(12):1402-1408.
63. van Spronsen F.J., Berger R., Smit G.P., et al. Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem. J Inherit Metab Dis 1989, 12(Suppl 2):339-342.
64. Santra S., Baumann U. Experience of nitisinone for the pharmacological treatment of hereditary tyrosinaemia type 1. Expert Opin Pharmacother 2008, 9(7):1229-1236.
65. Eriksson S., Carlson J., Velez R. Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency. N Engl J Med 1986, 314(12):736-739.
66. Zhou H., Fischer H.P. Liver carcinoma in PiZ alpha-1-antitrypsin deficiency. Am J Surg Pathol 1998, 22(6):742-748.
67. Alter B.P. Cancer in Fanconi anemia, 1927-2001. Cancer 2003, 97(2):425-440.
68. Cohen M.M. Beckwith-Wiedemann syndrome: historical, clinicopathological, and etiopathogenetic perspectives. Pediatr Dev Pathol 2005, 8(3):287-304.
69. Hughes L.J., Michels V.V. Risk of hepatoblastoma in familial adenomatous polyposis. Am J Med Genet 1992, 43(6):1023-1025.
70. Giardiello F.M., Offerhaus G.J., Krush A.J., et al. Risk of hepatoblastoma in familial adenomatous polyposis. J Pediatr 1991, 119(5):766-768.
71. Daroca P.J., Tuthill R., Reed R.J. Cholangiocarcinoma arising in congenital hepatic fibrosis. A case report. Arch Pathol 1975, 99(11):592-595.
72. Scheimann A.O., Strautnieks S.S., Knisely A.S., et al. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. J Pediatr 2007, 150(5):556-559.
73. Meikle P.J., Hopwood J.J., Clague A.E., et al. Prevalence of lysosomal storage disorders. JAMA 1999, 281(3):249-254.
74. De Braekeleer M., Larochelle J. Genetic epidemiology of hereditary tyrosinemia in Quebec and in Saguenay-Lac-St-Jean. Am J Hum Genet 1990, 47(2):302-307.
75. Green N.S., Dolan S.M., Murray T.H. Newborn screening: complexities in universal genetic testing. Am J Public Health 2006, 96(11):1955-1959.